Skip to main content
. Author manuscript; available in PMC: 2016 Apr 21.
Published in final edited form as: Am J Obstet Gynecol. 2015 Aug 12;213(6):844.e1–844.e6. doi: 10.1016/j.ajog.2015.08.014

TABLE 2.

Maternal body mass index and weight characteristics of women randomized to 17-alpha hydroxyprogesterone caproate or placebo

Description Value 17OHP-C
N = 294 (%)		 Placebo
N = 149 (%)		 P value
Maternal BMI
(continuous)		 Mean (SE) 26.5 (0.41) 25.5 (0.51) .147
Maternal BMI
(3-category)		 Normal/under
(BMI <25 kg/m2)		 137 (46.60) 80 (53.69) .291
Preobese
(BMI 25–29.9 kg/m2)		 64 (21.77) 32 (21.48)
Obese (BMI ≥30 kg/m2) 93 (31.63) 37 (24.83)
Maternal BMI
(6-category)		 Underweight 25 (8.50) 10 (6.71) .437
Normal BMI 112 (38.10) 70 (46.98)
Preobese 64 (21.77) 32 (21.48)
Obese I 46 (15.65) 16 (10.74)
Obese II 22 (7.48) 12 (8.05)
Obese III 25 (8.50) 9 (6.04)
Maternal weight
(continuous)		 Mean (SE) 154 (2.49) 148 (3.24) .149

17OHP-C, 17-alpha hydroxyprogesterone caproate; BMI, body mass index.